BSETrident Lifeline LtdMediumNeutral
Announced Tue, 9 Jun · 15:31 IST

We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....

Fund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹246.15
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-0.5+3.4-0.5+0.8-0.8+6.2+6.6
Up moveDown movePending
AI summary

Trident Lifeline Ltd's subsidiary, Trident Mediquip Limited (TML), has allotted equity shares to other shareholders via a private placement. As a result, Trident Lifeline's holding in TML has come down marginally from 59.17% to 58.84%, though TML remains a subsidiary. TML operates in the medical device industry with a paid-up share capital of Rs. 9.97 crore and has shown strong turnover growth — from Rs. 20.58 crore in FY24 to Rs. 21.29 crore in FY25 and Rs. 27.31 crore in FY26. The transaction involves related parties (promoter group members/directors' relatives) and has been carried out at arm's length.

Likely market impact

This is a routine subsidiary-level capital infusion that causes only a minor dilution (0.33%) in Trident Lifeline's stake. The growing turnover of TML is a positive sign for the group's consolidated performance, and the dilution impact on the listed entity is negligible.